Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

Delayed Data
As of Nov 25
 +0.28 / +5.37%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of 2.50. The median estimate represents a +91.26% increase from the last price of 5.49.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.60%
Growthannually 14.03%


Growthquarterly 69.39%
Growthannually 40.27%
Key to the earnings and sales forecast charts.